Report
AI companies run virtual drug trials, aiming to improve the success of human studies
Reuters reports that Novartis shares fell 11% after a late-stage trial of its experimental drug del-desiran missed its goal.
TLDR
Reuters reports that AI companies are running virtual drug trials in hopes of improving the success of human studies. Its report describes a recent setback: a late-stage trial of Novartis’ experimental del-desiran missed its goal, and the company’s shares fell 11%, erasing $30 billion in market value.
Combined views
32.4K
1 Source, first seen ago